Clinical Trial

Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Protein SOSIP v8.2 763 Vaccine, Adjuvanted With MPLA Liposomes, in Healthy, HIV-Uninfected Adults

Study acronym: HIVAC-FOUND
Unknown Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated July 10, 2024 (before its estimated June 2025 completion). Its status may not reflect the trial's current state.
Summary
Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Protein SOSIP v8.2 763 Vaccine, Adjuvanted with MPLA Liposomes, in Healthy, HIV-Uninfected Adults
Protocol Amendment History 1 change
critical Trial status changed: Active, Not Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT05772286
Lead Sponsor Fundacion Clinic per a la Recerca Biomédica
Collaborators: Polymun Scientific GmbH
Conditions Healthy
Enrollment 12 participants
Start Date 2023-07-24
Primary Completion 2025-06 (estimated)
Study Completion 2025-06 (estimated)
Updated on ClinicalTrials.gov 2024-07-10